Results 31 to 40 of about 5,180,843 (313)

ALZHEIMER’S DISEASE PROGNOSIS IS CAPTURED BY A DOWN-UPSIZED INCIDENCE POISSON DISTRIBUTION [PDF]

American Medical Journal, 2013
Alzeimer disease is a daunting nightmare to both the medical and families of the patients. Tireless efforts are made by the medical researchers to treat Alzheimer’s patients. The Alzhiemer patients’ data provides clues about its prognosis and they can be identifies when the data are analyzed and understood correctly.
openaire   +1 more source

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment [PDF]

, 2023
Data Availability Statement: All ADNI data are made publicly available upon request.Background: Neuropsychiatric symptoms (NPS) are associated with faster decline in mild cognitive impairment (MCI).
Arenare, G, Venneri, A, Caffarra, P, Manca, R   +3 more
core   +1 more source

A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease

Alzheimer’s Research & Therapy, 2022
Background Cerebrospinal fluid (CSF) tau and beta-amyloid levels in chronic traumatic encephalopathy (CTE), a disease which can be clinically indistinguishable from Alzheimer’s disease (AD), are largely unknown.
Katherine W. Turk, Alexandra Geada, Victor E. Alvarez, Weiming Xia, Jonathan D. Cherry, Raymond Nicks, Gaoyuan Meng, Sarah Daley, Yorghos Tripodis, Bertrand R. Huber, Andrew E. Budson, Brigid Dwyer, Neil W. Kowall, Robert C. Cantu, Lee E. Goldstein, Douglas I. Katz, Robert A. Stern, Michael L. Alosco, Jesse Mez, Ann C. McKee, Thor D. Stein   +20 more
doaj   +1 more source

Additional file 2: of The neuropathological diagnosis of Alzheimerâ s disease

, 2019
Figure S2. Clinical Diagnoses of 227 Patients with a Pathologic Diagnosis of Pure AD. More than a third of pathologic AD cases on the Mayo Clinic Brain Bank from 2007 to 2016 were not expected to have AD. (PPTX 52 kb)
DeTure, Michael, Dickson, Dennis
openaire   +1 more source

Optimal management of Alzheimer’s disease patients : clinical guidelines and family advice [PDF]

, 2010
Family members provide most of the patient care and administer most of the treatments to patients with Alzheimer’s disease (AD). Family caregivers have an important impact on clinical outcomes, such as quality of life (QoL).
Haberstroh, Julia, Hampel, Harald, Pantel, Johannes   +2 more
core   +1 more source

Dynamic amyloid and metabolic signatures of delayed recall performance within the clinical spectrum of Alzheimer’s disease [PDF]

, 2023
Associations between pathophysiological events and cognitive measures provide insights regarding brain networks affected during the clinical progression of Alzheimer’s disease (AD).
Shin, Monica, Gauthier, Serge G., Dauar, Marina Tedeschi, Pascoal, Tharick Ali, Rowley, Jared, Rosa Neto, Pedro, Poirier, Judes, Zimmer, Eduardo Rigon, Fonov, Vladimir S., Mohaddes, Sara, Eskildsen, Simon Fristed, Therriault, Joseph   +11 more
core   +1 more source

Common age‐related neuropathologies and yearly variability in cognition

Annals of Clinical and Translational Neurology, 2019
Objective Cognitive variability is a potentially important source of heterogeneity in longitudinal cognitive profiles. We examined the extent to which common age‐related neuropathologies including Lewy bodies and Alzheimer’s disease (AD) contribute to ...
Lei Yu, Tianhao Wang, Robert S. Wilson, Sue Leurgans, Julie A. Schneider, David A. Bennett, Patricia A. Boyle   +6 more
doaj   +1 more source

Additional file 3: of The neuropathological diagnosis of Alzheimerâ s disease

, 2019
Figure S3. Pathologic Diagnoses in 626 Patients with Clinical Diagnosis of AD. The majority of clinical AD cases as observed in the Mayo Clinic Brain Bank from 2007 to 2016 were found to have co-pathologies. (PPTX 63 kb)
DeTure, Michael, Dickson, Dennis
openaire   +1 more source

Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer’s Coordinating Center Uniform Data Set

Alzheimer’s Research & Therapy, 2019
Background Longitudinal investigations are needed to improve understanding of the contributions of cerebral small vessel disease to the clinical manifestation of Alzheimer’s disease, particularly in the early disease stages.
Christian Puzo, Caroline Labriola, Michael A. Sugarman, Yorghos Tripodis, Brett Martin, Joseph N. Palmisano, Eric G. Steinberg, Thor D. Stein, Neil W. Kowall, Ann C. McKee, Jesse Mez, Ronald J. Killiany, Robert A. Stern, Michael L. Alosco   +13 more
doaj   +1 more source

MOESM1 of Plasma lipoproteome in Alzheimerâ s disease: a proof-of-concept study

, 2018
Additional file 1. Supplementary methods.
Li, Danni, Huang, Fangying, Zhao, Yingchun, Villata, Peter, Griffin, Timothy, Zhang, Lin, Li, Ling, Yu, Fang   +7 more
openaire   +1 more source